Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?

被引：0
|
作者：
Meinrad Gawaz
机构：
[1] Eberhard-Karls University of Tübingen,professor and Director of the Department of Medicine
来源：
Nature Clinical Practice Cardiovascular Medicine | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
  • [21] The influence of baseline platelet aggregation response on subsequent inhibition of aggregation achieved with clopidogrel or prasugrel
    Jakubowski, JA
    Weerakkody, GJ
    Winters, KJ
    Brandt, JT
    Naganuma, H
    Wallentin, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 378A - 379A
  • [22] Superior responder rate for inhibition of platelet aggregation with a 60 mg loading dose of prasugrel (CS-747, LY640315) compared with a 300 mg loading dose of clopidogrel
    Brandt, JT
    Payne, CD
    Weerakkody, G
    Behounek, BD
    Naganuma, H
    Jakubowski, JA
    Wiviott, SD
    Winters, KJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 87A - 87A
  • [23] COMPARISON OF PLATELET AGGREGATION BEFORE & AFTER LOADING DOSE OF PRASUGREL AND CLOPIDOGREL IN PERCUTANEOUS CORONARY INTERVENTION IN ADULT PAKISTANI CAD PATIENTS
    Nouman, A.
    Shahbaz, A.
    Mehdi, K.
    Azhar, M.
    THROMBOSIS RESEARCH, 2014, 133 : S43 - S43
  • [24] A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
    Brandt, John T.
    Payne, Christopher D.
    Wiviott, Stephen D.
    Weerakkody, Govinda
    Farid, Nagy A.
    Small, David S.
    Jaknbowski, Joseph A.
    Naganuma, Hideo
    Winters, Kenneth J.
    AMERICAN HEART JOURNAL, 2007, 153 (01) : 66.e9 - 66.e16
  • [25] Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI
    Hillegass, William B.
    Brott, Brigitta C.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (12)
  • [26] Underuse of prasugrel and ticagrelor in patients with chronic kidney disease despite achieving a more effective platelet inhibition than clopidogrel
    Lugo, L. M.
    Marcano, A. L.
    Gomez-Polo, J. C.
    Silva, I.
    Gomez-Hospital, J. A.
    Vivas, D.
    De La Hera, J. M.
    Tello-Montoliu, A.
    Marin, F.
    Cequier, A. R.
    Roldan, I.
    Ferreiro, J. L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 801 - 802
  • [27] Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: An integrated analysis
    Weerakkody, Govinda J.
    Jakubowski, Joseph A.
    Brandt, John T.
    Payne, Christopher D.
    Naganuma, Hideo
    Winters, Kenneth J.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 12 (03) : 205 - 212
  • [28] Prasugrel 60 mg versus Clopidogrel 600 mg: greater platelet inhibition with Prasugrel is explained by higher concentrations of the active metabolite
    Winters, K. J.
    Payne, C. D.
    Ernest, C. S.
    Li, G. Y.
    Farid, N. A.
    Jakubowski, J. A.
    Salazar, D. E.
    Small, D. S.
    EUROPEAN HEART JOURNAL, 2007, 28 : 218 - 218
  • [29] Prasugrel, but not clopidogrel, is effective in platelet inhibition in patients treated by therapeutic hypothermia after cardiac arrest for acute myocardial infarction
    Bednar, F.
    Osmancik, P.
    Marinov, I.
    Kroupa, J.
    Knot, J.
    Ulman, J.
    Motovska, Z.
    EUROPEAN HEART JOURNAL, 2013, 34 : 892 - 892
  • [30] Pharmacodynamic Assessment of Platelet Inhibition by Prasugrel versus Clopidogrel in the TRITON-TIMI 38 Trial
    Frelinger, Andrew L., III
    Michelson, Alan D.
    Braunwald, Eugene
    Downey, William E.
    Angiolillo, Dominick J.
    Xenopoulos, Nicholas P.
    Jakubowski, Joseph A.
    Li, Youfu
    Murphy, Sabina A.
    Qin, Jie
    McCabe, Carolyn H.
    Antman, Elliott M.
    Wiviott, Stephen D.
    CIRCULATION, 2008, 118 (18) : S814 - S814
12345